Mahvash Tavassoli
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
The role of the oral microbiome in oral cancer (OSCC).
Journal: Advances in immunology
Published: July 22, 2026
Microbiome-targeted therapeutics in head & neck cancer.
Journal: Advances in immunology
Published: July 22, 2026
Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck Cancer.
Journal: Cancers
Published: December 02, 2024
Evaluation of Pyrrolone-Fused Benzosuberene MK2 Inhibitors as Promising Therapeutic Agents for HNSCC: In Vitro Efficacy, In-Vivo Safety, and Pharmacokinetic Profiling.
Journal: Drug development research
Published: August 02, 2024
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
Journal: Oncology reports
Published: February 08, 2024
Crosstalk between CAFs and tumour cells in head and neck cancer.
Journal: Cell death discovery
Published: February 02, 2024
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma.
Journal: Cell death & disease
Published: July 19, 2023
Semisynthesis reveals apoptin as a tumour-selective protein prodrug that causes cytoskeletal collapse.
Journal: Chemical science
Published: August 10, 2022
EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma.
Journal: Cell death & disease
Published: July 05, 2022
EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
Journal: Cancer letters
Published: August 07, 2020
Last Updated: 09/26/2026